Skip to content
Yog Pharma
Central nervous systemSelective serotonin reuptake inhibitor (SSRI)

Escitalopram Oxalate is a selective serotonin reuptake inhibitor (SSRI) indicated for major depressive disorder and generalized anxiety disorder. We supply it to US manufacturers of tablets and oral solution.

CAS219861-08-2414.4 g/molC22H23FN2O5
2D structure of Escitalopram Oxalate, shown as the active moiety without counter-ion or water of hydration.

Data from PubChem (CID 146571) and FDA’s substance registry

CAS number

219861-08-2

Molecular formula

C22H23FN2O5

Molecular weight

414.4g/mol

FDA UNII

IUPAC name

(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid

InChIKey

KTGRHKOEFSJQNS-BDQAORGHSA-N

Appearance
Fine, white to almost white crystalline powder.
Solubility
Freely soluble in methanol and dimethyl sulfoxide, soluble in isotonic saline, sparingly soluble in water and ethanol, and insoluble in heptane.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

The single S-enantiomer of citalopram. The limit for the R-enantiomer is the figure to compare between sources.

On the US market

Reference product
LexaproNDA 021323
Approved ANDAs
17 with a marketed product
Approved forms and strengths
  • Tablet 5 mg, 10 mg, 20 mg
  • Oral solution 5 mg/5 mL
  • Capsule 15 mg

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com